Tubastatin-a, an HDAC6 inhibitor, was used in AD mice leading to alleviated behavioral deficits, alterations on amyloid-beta load and reduced tau phosphorylation (Zhang et al., 2014). The gene discussed is HDAC6; the disease is Alzheimer disease.